Data from ongoing Phase 1 study of AX-0810 in healthy volunteers demonstrated dose-dependent target engagement on all key ...
Modern OCT devices can look inside the eye without a scalpel - but they do not always capture everything that matters. Some ...
Phase 1b clinical trial of SYX-5219 in adults with moderate to severe atopic dermatitis completes enrollment ahead of scheduleRapid progress in ...
Sionna Therapeutics targets cystic fibrosis with novel CFTR/NBD1 stabilization; key 2026 readouts and cash runway to 2028.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said the last patient in its Phase 2a clinical trial has received a first dose of ...
Marvell is deeply embedded in AI infrastructure, focusing on custom silicon, optical connectivity, and networking, with major ...
Bupropion conferred modest reductions in cancer-related fatigue compared with placebo, according to results of a randomized ...
A new generation of reversible male contraceptives is advancing through clinical trials to expand family planning options.
BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) gradually strips people of command over their own bodies, advancing steadily with no available cure. More than 2.9 million people across the ...
Top line data readout expected in late Q3/early Q4; INFORM-MS trial is a randomized, double-blind, placebo-controlled Phase ...
3d
Cohere Technologies Wins $28 Million U.S. Government Contract to Develop Multi-Waveform RAN for ISAC
Multi-Waveform Wireless Prototype Will Deliver Operational Aerial Surveillance and Response ISAC is a mission-first ...
Detailed price information for Proqr Therapeutics (PRQR-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results